CN Patent

CN112979613B — 2-(1h-吡唑-3-基)吡啶衍生物及其制备方法和用途

Assigned to West China Hospital of Sichuan University · Expires 2022-04-26 · 4y expired

What this patent protects

本发明属于药物化学领域，具体涉及一种如式I所示化合物，或其立体异构体、或其盐、或其前药、或其溶剂化物，本发明还涉及其制备方法及其用于制备治疗由组蛋白去甲基化酶JMJD6介导的相关疾病的药物中的用途。

USPTO Abstract

本发明属于药物化学领域，具体涉及一种如式I所示化合物，或其立体异构体、或其盐、或其前药、或其溶剂化物，本发明还涉及其制备方法及其用于制备治疗由组蛋白去甲基化酶JMJD6介导的相关疾病的药物中的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN112979613B
Jurisdiction
CN
Classification
—
Expires
2022-04-26
Drug substance claim
No
Drug product claim
No
Assignee
West China Hospital of Sichuan University
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.